Nano delivery of MiR-146a and its effect study on genes involved in apoptosis and autophagy pathways in lung cancer and tuberculosis
Authors:
- Mojgan SheikhpourMSMojgan Sheikhpour
- Mobina MalekiMMMobina Maleki
- Hanie SakhiHSHanie Sakhi
- Abolfazl MovafaghAMAbolfazl Movafagh
- Seyed Ali NojoumiSNSeyed Ali Nojoumi
- Leila GhazizadehLGLeila Ghazizadeh
Open Access
- 11 August 2025
- journal article
- Published by Springer Nature in BMC Biotechnology
- Vol. 25 (1)
Abstract
Tuberculosis (TB) and lung cancer (LC) are among the leading causes of death worldwide and present serious challenges in diagnosis and treatment. Therefore, developing new strategies for their treatment is crucial. MicroRNAs (miRNAs) are biological molecules that play a critical role in regulating essential processes, such as apoptosis and autophagy, in TB and LC by targeting specific genes. Recently, carbon nanotubes functionalized with Polyethyleneimine (CNT-PEI) to deliver miRNAs to target cells have been investigated to enhance therapeutic effects. In this study, miR-146a was transfected into LC (A549), macrophages infected with TB (THP1), and healthy lung cells (MRC5) using CNT-PEI. Then, the expression of miR-146a and its target gene, TNF receptor-associated factor-6 (TRAF6), and other genes involved in apoptosis and autophagy pathways including BCL-2, IL-6, tumor necrosis factor-alpha (TNFα), were measured using Real-Time PCR. Finally, the effect of overexpression of miR-146a on these genes was investigated in all three cell lines. The results showed successful transfection of miR-146a using the CNT-PEI nano delivery system in LC and TB cell models. Then, increased expression of miR-146 increased apoptosis and autophagy by targeting the TRAF6 gene and affecting other genes such as BCL-2, IL-6, and TNFα through the NF-kB signaling pathway. The findings suggest an important role for miR-146a in TB and LC, which regulates inflammatory responses and treats these diseases. However, further studies are needed on using CNT-PEI in vivo, as well as the balance between local anti-inflammatory and non-inflammatory factors. The online version contains supplementary material available at 10.1186/s12896-025-01019-8.Keywords
All Related Versions
This publication has 54 references indexed in Scilit:
- MicroRNA-146a Represses Mycobacteria-Induced Inflammatory Response and Facilitates Bacterial Replication via Targeting IRAK-1 and TRAF-6PLOS ONE, 2013
- Attenuation of inflammatory mediator production by the NF-κB member RelB is mediated by microRNA-146a in lung fibroblastsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2013
- miR-146a Inhibits Cell Growth, Cell Migration and Induces Apoptosis in Non-Small Cell Lung Cancer CellsPLOS ONE, 2013
- Inductive microRNA‐21 impairs anti‐mycobacterial responses by targeting IL‐12 and Bcl‐2FEBS Letters, 2012
- TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancerJournal of Clinical Investigation, 2011
- MicroRNA-146a Downregulates NFκB Activity via Targeting TRAF6 and Functions as a Tumor Suppressor Having Strong Prognostic Implications in NK/T Cell LymphomaClinical Cancer Research, 2011
- Hybrid Polymer‐Grafted Multiwalled Carbon Nanotubes for In vitro Gene DeliverySmall, 2010
- MicroRNAs: Novel regulators in the hallmarks of human cancerCancer Letters, 2009
- Delivery of Telomerase Reverse Transcriptase Small Interfering RNA in Complex with Positively Charged Single-Walled Carbon Nanotubes Suppresses Tumor GrowthClinical Cancer Research, 2006
- A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.Proceedings of the National Academy of Sciences, 1995